检索

期
标题
作者
卷 96, 编号 5 (2024)
Reduction in the need for glucocorticoids on the background of therapy with biologic disease-modifying antirheumatic drugs and Janus kinase inhibitors in rheumatoid arthritis: evidence from real clinical practice
Potapova A., Karateev A., Polishchuk E., Filatova E., Amirdzhanova V., Lila A.
PDF
(Rus)
卷 95, 编号 12 (2023)
Real-world experience with netakimab in the treatment of spondyloarthritis
Meshkov A., Vorobyeva N., Ostapenko V., Pykhtina V., Ruzanova V., Perlova O., Kordyukova I., Naumov A., Khovasova N., Tkacheva O.
PDF
(Rus)
卷 94, 编号 2S (2022)
Visceral sensitivity in diagnostics and treatment of severe irritated bowel syndrome
Makarova A., Diukova G., Ruchkina I., Romashkina N., Indejkina L., Degterev D., Dbar S., Parfenov A.
PDF
(Rus)
卷 94, 编号 7 (2022)
Biochemical markers of thrombotic complications in the acute period of ischemic stroke
Kochetov A., Lyang O., Zhirova I., Ivoylov O.
PDF
(Rus)
卷 94, 编号 12 (2022)
Efficacy and safety of the use of alirocumab in real clinical practice
Korneva V., Kuznetsova T., Scopets I., Vezikova N.
PDF
(Rus)
卷 94, 编号 10 (2022)
Sub-analyses of the DAPA-CKD study: new data on the use of sodium-glucose cotransporter type 2 inhibitor in the treatment of chronic kidney disease
Shamkhalova M., Sukhareva O., Shestakova M.
PDF
(Rus)
卷 81, 编号 5 (2009)
Effects of renin-angiotensin system blockers on left ventricular hypertrophy and biochemical markers of collagen balance in patients with hypertensive hypertrophy
Ovchinnikov A., Serbul V., Ageev F., Ovchinnikov A., Serbul V., Ageev F.
卷 89, 编号 8 (2017)
Chronic gastritis: Instructions for use of medications
Simanenkov V., Vyalov S.
PDF
(Rus)
卷 83, 编号 12 (2011)
Thrombin-activated inhibitor of fibrinolysis and efficacy and safety of long-term warfarin treatment in patients with venous thromboembolic complications
Vorob'eva N., Panchenko E., Dobrovol'skiy A., Titaeva E., Ermolina O., Balakhonova T., Khasanova Z., Postnov A., Kirienko A., Vorobyeva N., Panchenko E., Dobrovolsky A., Titaeva E., Ermolina O., Balakhonova T., Khasanova Z., Postnov A., Kirienko A.
卷 80, 编号 6 (2008)
The role of matrix metalloproteinases in pathogenesis of renal disease
Bobkova I., Kozlovskaia L., Li O.
卷 89, 编号 5 (2017)
New horizons in the use of biological agents during pregnancy in patients with rheumatic disease
Shesternya P., Petrova M., Vasilyeva A.
PDF
(Rus)
卷 83, 编号 4 (2011)
Renin-angiotensin-aldosteron system: evolution of views from renin discovery to nowadays. Perspectives of therapeutic block
Shestakova M., Shestakova M.
卷 92, 编号 12 (2020)
Diagnosis of thrombotic thrombocytopenic purpura
Galstyan G., Klebanova E.
PDF
(Rus)
卷 88, 编号 9 (2016)
Role of vascular remodeling markers in the development of osteoporosis in idiopathic pulmonary arterial hypertension
Nevzorova V., Kochetkova E., Ugay L., Maistrovskaya Y., Khludeeva E.
PDF
(Rus)
卷 83, 编号 6 (2011)
Determination of urinary markers of proteolysis/fibrinolysis and fibroangiogenesis in the kidney in hypertensive patients
Nanchikeeva M., Kozlovskaya L., Rameev V., Fomin V., Bulanov N., Nanchikeeva M., Kozlovskaya L., Rameev V., Fomin V., Bulanov N.
卷 92, 编号 5 (2020)
Possibility of complex medicamental and endovascular treatment of pulmonary hypertension in Takayasu arteritis with predominant pulmonary arteries’ lesion
Маrtynuk T., Aleevskaya A., Gramovich V., Danilov N., Korobkova I., Matchin U., Solodovnikova L., Beketova T.
PDF
(Rus)
卷 86, 编号 9 (2014)
A fixed-dose lisinopril and amlodipine combination in conjunction with rosuvastatin in patients with hypertensive disease and coronary heart disease
Galeeva Z., Galiavich A.
卷 82, 编号 11 (2010)
Raltegravir is the first HIV integrase inhibitor as part of antiretroviral treatment regimens
Kravchenko A., Kravchenko A.
卷 91, 编号 8 (2019)
The relationship between the combined use of various proton pump inhibitors with antiplatelet drugs and the risk of cardiovascular complications
Ostroumova O., Kochetkov A., Pereverzev A., Kravchenko E., Kazjulin A., Andreev D., Pavleeva E.
PDF
(Rus)
卷 85, 编号 6 (2013)
General molecular and cellular mechanisms for renal and cardiac remodeling in chronic kidney disease: a target for nephrocardioprotection
Kozlovskaia L., Bobkova I., Nanchikeeva M., Chebotareva N., Li O., Plieva O.
卷 82, 编号 2 (2010)
The parameters of collagen proteolytic and metabolic systems in chronic liver diseases of viral and toxic etiologies
Beloborodova E., Beloborodova E., Akbasheva O., Serebrov V., Chernogoryuk G., Rachkovskiy M., Purlik I., Ostanko V., Chvyrina D., Beloborodova E., Beloborodova E., Akbasheva O., Serebrov V., Chernogoryuk G., Rachkovsky M., Purlik I., Ostanko V., Chvyrina D.
卷 90, 编号 9 (2018)
PCSK9 Inhibitor causes a decrease in the level of oxidatively modified low-density lipoproteins in patients with coronary artery diseases
Lankin V., Tikhaze A., Viigimaa M., Chazova I.
PDF
(Rus)
卷 85, 编号 2 (2013)
Boceprevir: New possibilities for the antiviral treatment of chronic hepatitis C
Nikitin I., Baĭkova I., Gogova L., Volynkina V., Kisliakov V.
卷 81, 编号 6 (2009)
Combined treatment of gastric ulcers induced by nonsteroid anti-inflammatory drugs. Results of 4-week population-based controlled trial of efficacy of proton pump inhibitor combination with tripotassium bismuth dicitrate
Karateev A., Uspenskiy Y., Pakhomova I., Nasonov E., Karateev A., Uspensky Y., Pakhomova I., Nasonov E.
卷 90, 编号 7 (2018)
Literature review and clinical observation of acquired idiopathic hemophilia with a new missense mutation in the factor VIII gene (His2026Arg)
ERSHOV V., GADAEV I., BUDANOVA D., PERINA F., SURIN V., SALOMASHKINA V., PSHENICHNIKOVA O., ZOZULYA N.
PDF
(Rus)
卷 85, 编号 1 (2013)
Plasminogen activator inhibitor type 1 gene polymorphism and thromboses in patients with antiphospholipid syndrome
Reshetniak T., Ostriakova E., Patrusheva2 N., Patrushev L., Aleksandrova E., Seredavkina N., Volkov A., Nasonov E.
卷 89, 编号 12 (2017)
Effect of an angiotensin-converting-enzyme inhibitor on the plasma concentration of cytokines and vasoactive molecules in patients with coronary heart disease and hypertension
Khadartsev A., Logatkina A., Terekhov I., Bondar S., Bondar N.
卷 84, 编号 5 (2012)
THE LEVELS OF PLASMINOGEN AND INHIBITOR OF PLASMINOGEN ACTIVATORS OF TYPE 1 IN ANTIPHOSPHOLIPID SYNDROME
Ostryakova E., Reshetnyak T., Aisina R., Mukhametova L., Gulin D., Alexandrova E., Seredavkina N., Varfolomeev S., Chernyakov A., Nikiforov Y., Nasonov E.
卷 81, 编号 2 (2009)
Regulators of fibrinolysis in chronic viral pathology of the liver
Yagoda A., Kopoy P., Yagoda A., Koroi P.
1 - 29 的 29 信息

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回（例如，隐含AND）
  • 使用OR结合多个检索词，便于查找含有这些检索词的文章，例如education OR research
  • 使用括号来创建更复杂的查询; 例如：archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如： "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如：online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语

##common.cookie##